Korea Business News Agency - NSP NEWS AGENCY.

(Seoul=NSP News Agency) eunyoung Huh Journalist = Samsung Electronics Vice Chairman Lee Jae-yong on 11th visited Samsung Biologics in Songdo, Incheon, to attend the completion ceremony of its fourth plant, the world’s single largest biopharmaceuticals manufacturing facility.

The new giant plant with a full production capacity of 240,000 liters per year has started the partial operation since October. Samsung has invested 2 trillion won in the construction of the plant.

The start of the partial operation of the fourth plant this year brought Samsung Biologics to the top in the CDMO industry as it came to secure a production capacity of 420,000 liters in total. Especially, in 2023, the production capacity is expected to grow to 600,000 liters when the new plant becomes fully operational.

Samsung expressed its will to build more plants - the fifth and the sixth following the completion of the fourth plant - to further advance the production technology and capacity and to become a ‘global biopharmaceutical manufacturing hub.’

Samsung Biologics now seeks to acquire a new land to build the second Biocampus as the fourth plant is now occupying much of the factory site.

Samsung also pledged to make an additional 7.5 trillion won investment in the bio industry over the next 10 years by 2032 to purchase a 363,636㎡ site and build the second campus with 4 more plants, making a huge and widening gap with other players in the industry.

NSP News Agency eunyoung Huh Journalist eunyoung114@nspna.com
Copyright ⓒ Korea's economic news agency NSP NEWS·NSP TV. All rights reserved-Redistribution Prohibited.